The analysis of free radicals, lipid peroxides, antioxidant enzymes and compounds related to oxidative stress as applied to the clinical chemistry laboratory
Efficacy and safety of LY3298176 (Tirzepatide), a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes (Phase 2 trial)
Where consumer-facing claims appeared to exceed the published evidence, we have erred toward the more conservative reading
A single mask costs about 2$
A root-cause approach is appropriate when pain persists despite medications, returns quickly after temporary relief, spreads beyond the original injury site, or when side effects begin to outweigh benefits
doi: 10.3389/fcimb.2025.1662442 Received 09 July 2025 Accepted 18 August 2025 Published 25 September 2025 Volume 15 - 2025 Edited by Yuanwei Zhang, Nanjing Normal University, China Reviewed by Estela Ruiz-Baca, Jurez University of the State of Durango, Mexico Antonio Vitiello, Ministry of Health, Rome, Italy Hu Pengjie, Chinese Academy of Sciences (CAS), China Updates Copyright 2025 Li, Liu, Jiang, Yang, Ni, Zhang and Tan